$AIP

Viana Antonio J sold $256K of AIP (indirect holdings)

Viana Antonio J sold 7,000 indirectly-held shares of Arteris, Inc. (AIP) at $36.51 ($0.26M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Viana Antonio J
Published Jun 5, 2026, 10:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The disclosed sale can marginally pressure sentiment, but the 10b5-1 pre-arranged nature typically lowers the informational content about near-term fundamentals.

02

Market read

A single disclosed insider sale with 10b5-1 plan; more relevant for monitoring than for immediate directional trading.

03

What to watch

Traders may overreact to single Form 4 prints; better signal comes from patterns (multiple consecutive sales, size vs. typical volume, or concurrent buys).

Relevance 6/10Novelty 6/10Timing: Filed after-hours/next-session disclosure (2026-06-05 filing; sale dated 2026-06-04).

Background

SEC Form 4 reports an insider transaction by a director of Arteris, Inc. (AIP).

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris director Viana Antonio J sold 7,000 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low probability of a sustained price move; any reaction is likely short-lived unless repeated selling accelerates.

Evidence & confidence

The filing is a routine insider sale with stated 10b5-1 plan usage, reducing interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity rather than sector-wide news.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than negative expectations.

Key entities

  • Arteris, Inc.

    Subject company; director sold 7,000 shares under a 10b5-1 plan.

  • Viana Antonio J

    Director who executed the open-market sale disclosed on Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to